{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:04:33Z","timestamp":1776881073146,"version":"3.51.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ritodrine hydrochloride, a \u03b22-adrenergic agonist, has been widely used in Asia and Europe to treat preterm labor in pregnant women. It has some typical side effects, such as palpitations, pulmonary edema, and hypokalemia. Here, we report a case of rhabdomyolysis and psychiatric symptoms might be associated with intravenous ritodrine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 32-year-old Chinese primigravida woman who was pregnant with twins by in vitro fertilization-embryo transfer was diagnosed with placenta previa and threatened abortion at 21 gestational weeks (GW). The patient was then treated with ritodrine hydrochloride. The initial dose of ritodrine was 150\u2009\u03bcg\/min, gradually increasing to 360\u2009\u03bcg\/min at 23<jats:sup>5\/7<\/jats:sup> GW and 400\u2009\u03bcg\/min at 27<jats:sup>1\/7<\/jats:sup> GW. Magnesium sulfate was added to the ritodrine regimen at 21<jats:sup>5\/7<\/jats:sup> GW in dosage of 1-2\u2009g\/h. Psychiatric symptoms appeared at 24<jats:sup>5\/7<\/jats:sup>, 26<jats:sup>5\/7<\/jats:sup>, and 27<jats:sup>3\/7<\/jats:sup> GW, manifesting as depression, anxiety, and suicidal tendencies. Severe muscle pain in her limbs and general weakness appeared after six weeks of ritodrine administration, which might have been a sign of rhabdomyolysis resulting from ritodrine administration. After ceasing the administration of ritodrine, the muscle pain and relevant data from laboratory tests on the patient were significantly improved, and her mood was stable. It is worth noting that this is the first time to report psychiatric symptoms may associated with the administration of ritodrine. In addition, we reviewed and analyzed six reported cases of rhabdomyolysis caused by ritodrine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our results suggest that we should pay more attention to the risk of rhabdomyolysis and psychiatric symptoms induced by intravenous ritodrine hydrochloride, especially in patients with a history of neuromuscular disorder, or concomitant use of magnesium sulfate.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-022-05299-2","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T09:06:49Z","timestamp":1673082409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ritodrine-induced rhabdomyolysis and psychiatric symptoms: a case report and literature review"],"prefix":"10.1186","volume":"23","author":[{"given":"Li","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4521-3117","authenticated-orcid":false,"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,7]]},"reference":[{"issue":"1","key":"5299_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/147323000903700128","volume":"37","author":"K Takagi","year":"2009","unstructured":"Takagi K, Satoh T. Is long-term tocolysis effective for threatened premature labour? J Int Med Res. 2009;37(1):227\u201339.","journal-title":"J Int Med Res"},{"issue":"12","key":"5299_CR2","doi-asserted-by":"publisher","first-page":"e018118","DOI":"10.1136\/bmjopen-2017-018118","volume":"7","author":"S Shinohara","year":"2017","unstructured":"Shinohara S, Sunami R, Uchida Y, Hirata S, Suzuki K. Association between total dose of ritodrine hydrochloride and pulmonary oedema in twin pregnancy: a retrospective cohort study in Japan. BMJ Open. 2017;7(12):e018118.","journal-title":"BMJ Open"},{"issue":"6","key":"5299_CR3","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1097\/AOG.0b013e31825af2f0","volume":"119","author":"ACOG","year":"2012","unstructured":"ACOG. practice bulletin no. 127: management of preterm labor. Obstet Gynecol. 2012;119(6):1308\u201317.","journal-title":"Obstet Gynecol"},{"key":"5299_CR4","doi-asserted-by":"publisher","first-page":"e6226","DOI":"10.1136\/bmj.e6226","volume":"345","author":"DM Haas","year":"2012","unstructured":"Haas DM, Caldwell DM, Kirkpatrick P, McIntosh JJ, Welton NJ. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. Bmj. 2012;345:e6226.","journal-title":"Bmj."},{"key":"5299_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40780-019-0137-3","volume":"5","author":"S Shimokawa","year":"2019","unstructured":"Shimokawa S, Sakata A, Suga Y, Isoda K, Itai S, Nagase K, et al. Incidence and risk factors of neonatal hypoglycemia after ritodrine therapy in premature labor: a retrospective cohort study. J Pharm Health Care Sci. 2019;5:7.","journal-title":"J Pharm Health Care Sci"},{"issue":"17","key":"5299_CR6","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1080\/14767058.2017.1323860","volume":"30","author":"GC Di Renzo","year":"2017","unstructured":"Di Renzo GC, Cabero Roura L, Facchinetti F, Helmer H, Hubinont C, Jacobsson B, et al. Preterm labor and birth management: recommendations from the European Association of Perinatal Medicine. J Matern Fetal Neonatal Med. 2017;30(17):2011\u201330.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"5299_CR7","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/AOG.0000000000004142","volume":"136","author":"Y Siegler","year":"2020","unstructured":"Siegler Y, Weiner Z, Solt I, ACOG. Practice Bulletin No. 217: Prelabor Rupture of Membranes. Obstet Gynecol. 2020;136(5):1061.","journal-title":"Obstet Gynecol"},{"key":"5299_CR8","unstructured":"European Medicines Agency: PRAC recommends restricted use of shortacting beta-agonists in obstetric indications. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Short-acting_betaagonists\/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee\/WC500148669.pdf. ."},{"issue":"1","key":"5299_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.5468\/ogs.2018.61.1.63","volume":"61","author":"MK Kim","year":"2018","unstructured":"Kim MK, Lee SM, Oh JW, Kim SY, Jeong HG, Kim SM, et al. Efficacy and side effect of ritodrine and magnesium sulfate in threatened preterm labor. Obstet Gynecol Sci. 2018;61(1):63\u201370.","journal-title":"Obstet Gynecol Sci"},{"issue":"1","key":"5299_CR10","doi-asserted-by":"publisher","first-page":"7804","DOI":"10.1038\/s41598-020-64687-w","volume":"10","author":"Y Yada","year":"2020","unstructured":"Yada Y, Ohkuchi A, Otsuki K, Goishi K, Takahashi M, Yonemoto N, et al. Synergic interaction between ritodrine and magnesium sulfate on the occurrence of critical neonatal hyperkalemia: a Japanese nationwide retrospective cohort study. Sci Rep. 2020;10(1):7804.","journal-title":"Sci Rep"},{"key":"5299_CR11","doi-asserted-by":"publisher","unstructured":"Sawhney JS, Kasotakis G, Goldenberg A, Abramson S, Dodgion C, Patel N, et al. Management of rhabdomyolysis: a practice management guideline from the eastern Association for the Surgery of trauma. Am J Surg. 2021.\u00a0https:\/\/doi.org\/10.1016\/j.amjsurg.2021.11.022.","DOI":"10.1016\/j.amjsurg.2021.11.022"},{"issue":"1","key":"5299_CR12","first-page":"139","volume":"28","author":"LZY Zhou","year":"2020","unstructured":"Zhou LZY, Wang L, Chen X. Diagnosis and treatment of rhabdomyolysis induced by ritodrine hydrochloride in the third trimester: a cese report and literature review. Chin J Fam Plann. 2020;28(1):139\u201340.","journal-title":"Chin J Fam Plann"},{"issue":"6","key":"5299_CR13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1515\/JPM.2002.080","volume":"30","author":"Y Matsuda","year":"2002","unstructured":"Matsuda Y, Nagayoshi Y, Kirihara N. Rhabdomyolysis during prolonged intravenous tocolytic therapy. J Perinat Med. 2002;30(6):514\u20136.","journal-title":"J Perinat Med"},{"issue":"1","key":"5299_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000088531","volume":"61","author":"K Nasu","year":"2006","unstructured":"Nasu K, Sugano T, Yoshimatsu J, Narahara H. Rhabdomyolysis caused by tocolysis with oral ritodrine hydrochloride in a pregnant patient with myotonic dystrophy. Gynecol Obstet Investig. 2006;61(1):53\u20135.","journal-title":"Gynecol Obstet Investig"},{"issue":"10","key":"5299_CR15","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.nmd.2009.06.364","volume":"19","author":"L Verriello","year":"2009","unstructured":"Verriello L, D'Amico D, Pauletto G, Gigli GL, Bergonzi P. Rhabdomyolysis caused by tocolytic therapy with ritodrine hydrochloride. Neuromuscul Disord. 2009;19(10):718\u201320.","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"5299_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/j.1447-0756.2010.01403.x","volume":"37","author":"Y Nakajima","year":"2011","unstructured":"Nakajima Y, Masaoka N, Tsuduki Y, Honda N, Sakai M. Rhabdomyolysis caused by tocolytic therapy with oral ritodrine hydrochloride in a pregnant woman with placenta previa. J Obstet Gynaecol Res. 2011;37(6):629\u201332.","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"5299_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/jog.13211","volume":"43","author":"M Ogoyama","year":"2017","unstructured":"Ogoyama M, Takahashi H, Kobayashi Y, Usui R, Matsubara S. Ritodrine-induced rhabdomyolysis, infantile myotonic dystrophy, and maternal myotonic dystrophy unveiled. J Obstet Gynaecol Res. 2017;43(2):403\u20137.","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"5299_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12884-019-2352-1","volume":"19","author":"D Shigemi","year":"2019","unstructured":"Shigemi D, Aso S, Yasunaga H. Inappropriate use of ritodrine hydrochloride for threatened preterm birth in Japan: a retrospective cohort study using a national inpatient database. BMC Pregnancy Childbirth. 2019;19(1):204.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"6","key":"5299_CR19","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1515\/JPM.2002.074","volume":"30","author":"Y Matsuda","year":"2002","unstructured":"Matsuda Y, Nagayoshi Y, Kirihara N. Evaluation of creatine kinase level during long-term tocolysis. J Perinat Med. 2002;30(6):476\u20139.","journal-title":"J Perinat Med"},{"issue":"13","key":"5299_CR20","doi-asserted-by":"publisher","first-page":"7211","DOI":"10.3390\/ijerph18137211","volume":"18","author":"JM Liu","year":"2021","unstructured":"Liu JM, Liu CY, Hsu RJ, Chang FW. Preterm labor using Tocolysis as a possible risk factor for postpartum depression: a 14-year population-based study in Taiwan. Int J Environ Res Public Health. 2021;18(13):7211.","journal-title":"Int J Environ Res Public Health"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-05299-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-022-05299-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-05299-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T15:44:25Z","timestamp":1673365465000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-022-05299-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,7]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5299"],"URL":"https:\/\/doi.org\/10.1186\/s12884-022-05299-2","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,7]]},"assertion":[{"value":"10 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}